JP2010535829A5 - - Google Patents

Download PDF

Info

Publication number
JP2010535829A5
JP2010535829A5 JP2010520498A JP2010520498A JP2010535829A5 JP 2010535829 A5 JP2010535829 A5 JP 2010535829A5 JP 2010520498 A JP2010520498 A JP 2010520498A JP 2010520498 A JP2010520498 A JP 2010520498A JP 2010535829 A5 JP2010535829 A5 JP 2010535829A5
Authority
JP
Japan
Prior art keywords
ethylsulfonyl
naphthalen
polymorphs
oxazole
benzo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010520498A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010535829A (ja
Filing date
Publication date
Priority claimed from GBGB0715937.9A external-priority patent/GB0715937D0/en
Application filed filed Critical
Publication of JP2010535829A publication Critical patent/JP2010535829A/ja
Publication of JP2010535829A5 publication Critical patent/JP2010535829A5/ja
Pending legal-status Critical Current

Links

JP2010520498A 2007-08-15 2008-08-14 デュシェンヌ型筋ジストロフィーの治療用の化合物の多形体 Pending JP2010535829A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0715937.9A GB0715937D0 (en) 2007-08-15 2007-08-15 Method of treatment og duchenne muscular dystrophy
PCT/EP2008/006718 WO2009021748A2 (en) 2007-08-15 2008-08-14 Polymorphs of a compound for the treatment of duchenne muscular dystrophy

Publications (2)

Publication Number Publication Date
JP2010535829A JP2010535829A (ja) 2010-11-25
JP2010535829A5 true JP2010535829A5 (cg-RX-API-DMAC7.html) 2011-09-29

Family

ID=38566447

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010520499A Pending JP2010535830A (ja) 2007-08-15 2008-08-14 デュシェンヌ型筋ジストロフィーの治療用化合物の製造
JP2010520498A Pending JP2010535829A (ja) 2007-08-15 2008-08-14 デュシェンヌ型筋ジストロフィーの治療用の化合物の多形体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2010520499A Pending JP2010535830A (ja) 2007-08-15 2008-08-14 デュシェンヌ型筋ジストロフィーの治療用化合物の製造

Country Status (17)

Country Link
US (2) US20090048314A1 (cg-RX-API-DMAC7.html)
EP (2) EP2188270A2 (cg-RX-API-DMAC7.html)
JP (2) JP2010535830A (cg-RX-API-DMAC7.html)
KR (1) KR20100075777A (cg-RX-API-DMAC7.html)
CN (2) CN101896475A (cg-RX-API-DMAC7.html)
AR (1) AR068810A1 (cg-RX-API-DMAC7.html)
AU (2) AU2008286325A1 (cg-RX-API-DMAC7.html)
BR (2) BRPI0811315A2 (cg-RX-API-DMAC7.html)
CA (2) CA2685590A1 (cg-RX-API-DMAC7.html)
CL (1) CL2008002391A1 (cg-RX-API-DMAC7.html)
GB (1) GB0715937D0 (cg-RX-API-DMAC7.html)
IL (1) IL201908A0 (cg-RX-API-DMAC7.html)
MX (2) MX2009011967A (cg-RX-API-DMAC7.html)
PE (1) PE20090604A1 (cg-RX-API-DMAC7.html)
RU (1) RU2009141831A (cg-RX-API-DMAC7.html)
TW (1) TW200911767A (cg-RX-API-DMAC7.html)
WO (2) WO2009021749A2 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1986633T3 (pl) * 2006-02-10 2015-01-30 Summit Oxford Ltd Leczenie dystrofii mięśniowej Duchenne'a
GB201208178D0 (en) 2012-05-10 2012-06-20 Summit Corp Plc Pharmaceutical composition for the treatment of duchenne muscular dystrophy
GB201412010D0 (en) 2014-07-04 2014-08-20 Summit Corp Plc Treatment of hypertransaminasemia
MX2018012018A (es) 2016-03-30 2019-07-04 Summit Oxford Ltd Composicion para el tratamiento de la distrofía muscular de duchenne.
WO2017175842A1 (ja) * 2016-04-07 2017-10-12 国立大学法人京都大学 スプライシングの改変に関する化合物及び医薬組成物
KR102019048B1 (ko) 2017-02-06 2019-09-09 가톨릭대학교 산학협력단 MG53과 Orai1의 결합을 이용한 근육긴장저하 치료제 스크리닝 방법
KR101886788B1 (ko) 2017-02-07 2018-08-09 가톨릭대학교 산학협력단 MG53과 Orai1의 결합을 이용한 뒤시엔느 골격근 위축증 치료제 스크리닝 방법
EP3641741B1 (en) 2017-06-19 2024-03-20 University of Maryland, Baltimore Microtubule polymerization inhibitor prodrugs and methods of using the same

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993659A (en) * 1971-08-10 1976-11-23 Ciba-Geigy Corporation Bis-benzoxazolyl-naphthalenes as optical brighteners
CH617809GA3 (cg-RX-API-DMAC7.html) * 1975-10-10 1980-06-30
US4110246A (en) * 1976-05-13 1978-08-29 Hoechst Aktiengesellschaft Mixture of benzoxazole derivatives
DE3027479A1 (de) * 1980-07-19 1982-03-04 Hoechst Ag, 6000 Frankfurt Mischungen von optischen aufhellern und deren verwendung
JPS615071A (ja) * 1984-06-15 1986-01-10 Fuji Photo Film Co Ltd ベンゾオキサゾ−ル誘導体
DE3617451A1 (de) * 1986-05-23 1987-11-26 Hoechst Ag Sulfonat- oder sulfonamidgruppen-haltige bis-benzoxazolylnaphthaline, verfahren zu deren herstellung und deren verwendung
DE3819051A1 (de) * 1988-06-04 1989-12-07 Agfa Gevaert Ag Farbfotografisches aufzeichnungsmaterial
DE59206989D1 (de) * 1991-08-08 1996-10-02 Ciba Geigy Ag Farbstoffe, Verfahren zu deren Herstellung und deren Verwendung
ES2157268T5 (es) * 1994-02-24 2004-12-01 SYMRISE GMBH & CO KG Preparados cosmeticos y dermatologicos que contienen acidos fenilen-1,4-bisbencimidazolsulfonicos.
US6004719A (en) * 1994-04-25 1999-12-21 Polaroid Corporation Imaging medium and process for producing an image
JP3928070B2 (ja) * 1994-06-30 2007-06-13 スリーエム カンパニー 硬化指示性成形及びコーティング組成物
CA2191238C (en) * 1994-06-30 2004-01-27 Joel D. Oxman Dental impression material with cure-indicating dye
US5567843A (en) * 1995-03-20 1996-10-22 The Dow Chemical Company Process for making 2-aryl benz (ox, thi, imid)azoles and 2-aminoaryl aminobenz(ox, thi, imid)azoles
US6222044B1 (en) * 1995-03-20 2001-04-24 The Dow Chemical Company Process for making 2-aryl benz (ox, thi, imid) azoles and 2-aminoaryl aminobenz (ox, thi, imid) azoles
US5977101A (en) * 1995-06-29 1999-11-02 Smithkline Beecham Corporation Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity
US5645948A (en) * 1996-08-20 1997-07-08 Eastman Kodak Company Blue organic electroluminescent devices
US6110638A (en) * 1996-11-27 2000-08-29 Polaroid Corporation Process and composition for generation of acid
US5914213A (en) * 1996-11-27 1999-06-22 Polaroid Corporation Process and composition for generation of acid
US6177572B1 (en) * 1997-08-20 2001-01-23 Sepracor, Inc. Solid and liquid-phase synthesis of benzoxazoles and benzothiazoles and their use
US6312822B1 (en) * 1998-05-28 2001-11-06 Eastman Chem Co Dispersion aids for optical brighteners in polyolefins
GB9815880D0 (en) * 1998-07-21 1998-09-16 Pfizer Ltd Heterocycles
US6436558B1 (en) * 1998-08-07 2002-08-20 Fuji Photo Film Co., Ltd. Organic electroluminescence element
FR2789582B1 (fr) * 1999-02-12 2001-05-04 Oreal Compositions photoprotectrices contenant un derive de bis-resorcinyl triazine et un compose a groupements benzoazolyle ou benzodiazolyle
FR2789581B1 (fr) * 1999-02-12 2001-05-04 Oreal Compositions photoprotectrices contenant un derive de benzotriazole, un derive de bis-resorcinyl triazine et un compose a groupements benzoazolyle ou benzodiazolyle
WO2000068210A1 (de) * 1999-05-07 2000-11-16 Basf Aktiengesellschaft Benzohetero cyclylcyclo hexenone und ihre verwendung als herbizide
WO2000068228A1 (de) * 1999-05-07 2000-11-16 Basf Aktiengesellschaft 4-(3',4'-heterocyclylbenzoyl) pyrazole als herbizide
FR2794645B1 (fr) * 1999-06-08 2001-08-10 Oreal Compositions photoprotectrices contenant un compose hydrocarbone bis-hydroxyphenylbenzotriazole et un compose a groupements benzoazolyle ou benzodiazolyle
US6770644B1 (en) * 1999-09-24 2004-08-03 Ono Pharmaceuticals Co., Ltd. Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient
US6565987B2 (en) * 1999-11-12 2003-05-20 Eastman Chemical Company Non-exuding optically brightened polyolefin blends
US6716413B1 (en) * 2000-10-16 2004-04-06 Mallinckrodt, Inc. Indole compounds as tissue-specific exogenous optical agents
WO2002044189A1 (fr) * 2000-11-30 2002-06-06 Canon Kabushiki Kaisha Element luminescent et afficheur
US20050261298A1 (en) * 2002-01-18 2005-11-24 David Solow-Cordero Methods of treating conditions associated with an Edg-7 receptor
US20050113283A1 (en) * 2002-01-18 2005-05-26 David Solow-Cordero Methods of treating conditions associated with an EDG-4 receptor
CN101613321A (zh) * 2002-03-05 2009-12-30 特兰斯泰克制药公司 抑制配体与高级糖化终产物受体相互作用的单和双环吡咯衍生物
EP1547996A4 (en) * 2002-08-30 2006-08-02 Bf Res Inst Inc DIAGNOSTIC PROBES AND REMEDIES FOR DISEASES IN WHICH PRION PROTEIN IS ACCUMULATED, AND ANIMAL FEVERING FOR PRION PROTEIN
AU2004247627A1 (en) * 2003-05-16 2004-12-23 Ambit Biosciences Corporation Pyrrole compounds and uses thereof
WO2005000295A1 (en) * 2003-05-20 2005-01-06 Transtech Pharma, Inc. Rage antagonists as agents to reverse amyloidosis and diseases associated therewith
JP4895811B2 (ja) * 2003-09-11 2012-03-14 ケミア,インコーポレイテッド サイトカイン阻害剤
WO2005029187A1 (en) * 2003-09-22 2005-03-31 Agfa-Gevaert Photopolymerizable composition.
US7097888B2 (en) * 2003-12-15 2006-08-29 Eastman Kodak Company Aligned liquid crystal layer containing azolium salts and process for increasing the tilt
US7592373B2 (en) * 2003-12-23 2009-09-22 Boehringer Ingelheim International Gmbh Amide compounds with MCH antagonistic activity and medicaments comprising these compounds
WO2005074375A2 (en) * 2004-02-06 2005-08-18 Insight Biopharmaceuticals Ltd Heparanase inhibitors and uses thereof
MY144903A (en) * 2004-06-17 2011-11-30 Novartis Ag Pyrrolopyridine derivatives and their use as crth2 antagonists
KR100718765B1 (ko) * 2004-08-19 2007-05-15 주식회사 엘지화학 버퍼층을 포함하는 유기 발광 소자 및 이의 제작 방법
US7723340B2 (en) * 2005-01-13 2010-05-25 Signal Pharmaceuticals, Llc Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
ZA200707896B (en) * 2005-03-14 2009-07-29 High Point Pharma Llc Benzazole derivatives, compositions, and methods of use as B-secretase inhibitors
JP2007086165A (ja) * 2005-09-20 2007-04-05 Fujifilm Corp 感光性組成物、これを用いた平版印刷版原版及び画像記録方法
KR101408026B1 (ko) * 2005-12-02 2014-06-20 사켐,인코포레이티드 음이온-교환 치환 크로마토그래피 공정 및 음이온-교환치환 크로마토그래피 공정에서 디스플레이서 화합물들로서사용하기 위한 음이온성 유기 화합물들
KR101213485B1 (ko) * 2006-01-27 2012-12-18 삼성디스플레이 주식회사 유기 금속 착물 및 이를 이용한 유기 전계 발광 소자
KR101213486B1 (ko) * 2006-02-02 2012-12-20 삼성디스플레이 주식회사 유기 금속 착물 및 이를 이용한 유기 전계 발광 소자
PL1986633T3 (pl) * 2006-02-10 2015-01-30 Summit Oxford Ltd Leczenie dystrofii mięśniowej Duchenne'a
KR101325062B1 (ko) * 2006-05-19 2013-11-05 삼성디스플레이 주식회사 발광 이종 핵 구리-이리듐 착체 및 이를 이용한 유기 전계발광 소자

Similar Documents

Publication Publication Date Title
JP2010535829A5 (cg-RX-API-DMAC7.html)
JP2009541403A5 (cg-RX-API-DMAC7.html)
JP2010501534A5 (cg-RX-API-DMAC7.html)
JP2010507682A5 (cg-RX-API-DMAC7.html)
JP2009149903A5 (cg-RX-API-DMAC7.html)
JP2011508438A5 (cg-RX-API-DMAC7.html)
JP2009535462A5 (cg-RX-API-DMAC7.html)
JP2010536766A5 (cg-RX-API-DMAC7.html)
JP2009524695A5 (cg-RX-API-DMAC7.html)
JP2007269812A5 (cg-RX-API-DMAC7.html)
WO2007087416A3 (en) Methods of increasing oral bioavailability of tetracyclines
JP2011523810A5 (cg-RX-API-DMAC7.html)
JP2010504301A5 (cg-RX-API-DMAC7.html)
JP2013500200A5 (cg-RX-API-DMAC7.html)
JP2009544651A5 (cg-RX-API-DMAC7.html)
JP2012042477A5 (cg-RX-API-DMAC7.html)
JP2013532130A5 (cg-RX-API-DMAC7.html)
EP2146979A4 (en) NOVEL PROCESS FOR THE MANUFACTURE OF 2-HYDROXY-3- [5- (MORPHOLIN-4-YLMETHYL) PYRIDIN-2-YL] 1H-INDOLE-5-CARBONITRILE 701
JP2013521273A5 (cg-RX-API-DMAC7.html)
JP2008266364A5 (cg-RX-API-DMAC7.html)
JP2011511794A5 (ja) 塩の製造のための方法
JP2010514800A5 (cg-RX-API-DMAC7.html)
JP2006506499A5 (cg-RX-API-DMAC7.html)
WO2009021748A3 (en) Polymorphs of a compound for the treatment of duchenne muscular dystrophy
JP2008248311A5 (cg-RX-API-DMAC7.html)